Rotator Cuff Impingement Syndrome
Conditions
Keywords
rotator cuff disorder
Brief summary
To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients
Detailed description
Objective: To evaluate the correlations between structure of supraspinatus tendon (impingement, tendinopathy or partial tear, as well as full thickness tear) on ultrasonography and its response to subacromial hyaluronic acid injection in rotator cuff disease patients and also investigate the factors associated with clinically important improvement after subdeltoid hyaluronic acid for rotator cuff disorder. Design: Prospective, longitudinal comparison study. Participants: Patients with rotator cuff disease Intervention: Three subacromial injection with hyaluronic acid with 2 week-interval. Main Outcome Measures: Visual analog scale (VAS) of the shoulder pain, Constant score, SPADI score, and angles of active shoulder range of motion (flexion, abduction, external rotation, and internal rotation) at pre-treatment, post-treatment at week 4 and post-treatment at week 12.
Interventions
DRUGHyaluronic Acid
Hyaluronic Acid 2cc into subacromial bursa at weeks 0, 2 and 4
Sponsors
Taipei Veterans General Hospital, Taiwan
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Masking description
outcome assessor does not know the rotator cuff condition of patients
Intervention model description
patients with rotator cuff disorders receving subacromial hyaluronic acid injection
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
were patients 1. with clinically and ultrasonographically diagnosed rotator cuff disease of the shoulder-impingement, tendinosis and tear; 2. who reported shoulder pain more than 3 months;
Exclusion criteria
1. presence of another medical or psychological condition, including cancer, rheumatoid arthritis, endocrine disease (i.e., diabetes), major depression, or schizophrenia; 2. previous major trauma history at currently affected shoulder; 3 primary osteoarthritis of the glenohumeral joint in a simple radiograph; 4previous injection history at the affected shoulder within 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| constant shoulder score | 12 weeks | the total constant score ranges from 0 to 100 points, with higher scores indicative of better function. The score is divided into four sections: pain, activity of daily living, ROM and the total constant score ranges from 0 to 100 points, with higher scores indicative of better function. The score is divided into four sections: pain, activity of daily living, ROM and strength |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| pain intensity measured by visual analog scale | 0, 6, 12 weeks | pain intensity was measured by visual analog scale. the total score ranges from 0 to 10 points, with higher scores indicative of more painful |
| Shoulder Pain And disability index | 0, 6, 12 weeks | The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder. |
| glenohumeral joint range of motion | 0, 6, 12 weeks | Shoulder flexion, abduction, external rotation and internal rotation were measured with goniometer with patient in supine position |
Countries
Taiwan
Contacts
Primary ContactJia Chi Wang, MD
Outcome results
None listed